Rational combination of dual PI3K/mTOR blockade and Bcl-2/-xL inhibition in AML.
about
The Complexity of Targeting PI3K-Akt-mTOR Signalling in Human Acute Myeloid Leukaemia: The Importance of Leukemic Cell Heterogeneity, Neighbouring Mesenchymal Stem Cells and Immunocompetent CellsRational Combinations of Targeted Agents in AMLFunctional oncogene signatures guide rationally designed combination therapies to synergistically induce breast cancer cell death.Outlook on PI3K/AKT/mTOR inhibition in acute leukemia.Des-gamma-carboxy prothrombin antagonizes the effects of Sorafenib on human hepatocellular carcinoma through activation of the Raf/MEK/ERK and PI3K/Akt/mTOR signaling pathways.Curcumin inhibits cell proliferation and promotes apoptosis of laryngeal cancer cells through Bcl-2 and PI3K/Akt, and by upregulating miR-15a.
P2860
Rational combination of dual PI3K/mTOR blockade and Bcl-2/-xL inhibition in AML.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Rational combination of dual PI3K/mTOR blockade and Bcl-2/-xL inhibition in AML.
@ast
Rational combination of dual PI3K/mTOR blockade and Bcl-2/-xL inhibition in AML.
@en
type
label
Rational combination of dual PI3K/mTOR blockade and Bcl-2/-xL inhibition in AML.
@ast
Rational combination of dual PI3K/mTOR blockade and Bcl-2/-xL inhibition in AML.
@en
prefLabel
Rational combination of dual PI3K/mTOR blockade and Bcl-2/-xL inhibition in AML.
@ast
Rational combination of dual PI3K/mTOR blockade and Bcl-2/-xL inhibition in AML.
@en
P2093
P2860
P1476
Rational combination of dual PI3K/mTOR blockade and Bcl-2/-xL inhibition in AML.
@en
P2093
Pankit Vachhani
Prithviraj Bose
Steven Grant
P2860
P304
P356
10.1152/PHYSIOLGENOMICS.00173.2013
P577
2014-05-13T00:00:00Z